about
A RNAi-based therapeutic proof of concept targets salmonid whirling disease in vivoThe high-affinity binding site for tricyclic antidepressants resides in the outer vestibule of the serotonin transporter.The serotonin transporter is an exclusive client of the coat protein complex II (COPII) component SEC24C.Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer.Molecular Biomarkers: their significance and application in marine pollution monitoring.A tale of two sites: How ubiquitination of a G protein-coupled receptor is coupled to its lysosomal trafficking from distinct receptor domains.Whirling disease revisited: pathogenesis, parasite biology and disease intervention.Mercury-induced genotoxicity in marine diatom (Chaetoceros tenuissimus).Tetracapsuloides bryosalmonae infection affects the expression of genes involved in cellular signal transduction and iron metabolism in the kidney of the brown trout Salmo trutta.Evaluation of impairment of DNA in marine gastropod, Morula granulata as a biomarker of marine pollution.DNA damage in marine rock oyster (Saccostrea Cucullata) exposed to environmentally available PAHs and heavy metals along the Arabian Sea coast.Ligand Selectivity among the Dopamine and Serotonin Transporters Specified by the Forward Binding Reaction.Evaluation of the impact of bioaccumulation of PAH from the marine environment on DNA integrity and oxidative stress in marine rock oyster (Saccostrea cucullata) along the Arabian sea coast.Development of an N-Acyl Amino Acid That Selectively Inhibits the Glycine Transporter 2 To Produce Analgesia in a Rat Model of Chronic PainAcetylcholinesterase activities in marine snail (Cronia contracta) as a biomarker of neurotoxic contaminants along the Goa coast, West coast of IndiaCan RNAi Target Salmonid Whirling Disease In Vivo?Photoswitchable ORG25543 Congener Enables Optical Control of Glycine Transporter 2
P50
Q33757759-E6F14914-AF5B-4B36-8425-7EBDEDC7A2D7Q34137102-15CF7DD4-2056-4745-846E-30EA5477A982Q34963789-5E5E0094-83CC-4161-940F-B5AB08DF6FCEQ35531894-82A05394-CFFC-4E4E-8EC7-10BDAD141109Q36468956-6C5AAD09-AE01-4F66-B634-5AEDE6257D75Q37951943-A768AE10-1E6F-4771-B1AA-247E898F3887Q38494204-68AC9178-1C43-4AFE-9995-986304A9DF27Q40455191-BDC1235C-56F5-4741-ABCA-AC69CB456538Q40636691-A048B2E3-D594-4C51-9699-630D7816138CQ46889536-359537C4-0EA8-4842-88DC-C94B9BECC1FFQ47717459-EE09065B-C3CF-4481-AE8A-2C927CE6FE91Q47721135-248D6FD9-65F7-4286-8999-BBAA78950027Q47952622-2A8A65AE-371D-430B-A0CC-A30E3727A581Q64267066-B3328CE3-2F8C-4E16-BF8E-4C70C9A7C480Q83290191-3A06D895-836C-4DB1-8BA3-46EFD24D934CQ85705482-D7E566DE-C089-4303-BBB3-57011F148464Q90456480-1E898D92-5BB3-427D-A61B-B6108F6C7052
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Subhodeep Sarker
@ast
Subhodeep Sarker
@en
Subhodeep Sarker
@es
Subhodeep Sarker
@nl
type
label
Subhodeep Sarker
@ast
Subhodeep Sarker
@en
Subhodeep Sarker
@es
Subhodeep Sarker
@nl
prefLabel
Subhodeep Sarker
@ast
Subhodeep Sarker
@en
Subhodeep Sarker
@es
Subhodeep Sarker
@nl
P106
P1153
15723639900
P31
P496
0000-0002-2222-2072